Efficacy of FP-025: A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma
Jazyk angličtina Země Dánsko Médium print-electronic
Typ dokumentu dopisy, práce podpořená grantem
PubMed
36094742
PubMed Central
PMC10087922
DOI
10.1111/all.15513
Knihovny.cz E-zdroje
- MeSH
- bronchiální astma * farmakoterapie MeSH
- lidé MeSH
- matrixová metaloproteinasa 12 * MeSH
- myši MeSH
- plíce MeSH
- sloučeniny síry MeSH
- tkáňový inhibitor metaloproteinasy 1 MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- dopisy MeSH
- práce podpořená grantem MeSH
- Názvy látek
- FP-025 MeSH Prohlížeč
- matrixová metaloproteinasa 12 * MeSH
- sloučeniny síry MeSH
- tkáňový inhibitor metaloproteinasy 1 MeSH
Department of Microbiology Immunology and Transplantation KU Leuven Leuven Belgium
Department of Pulmonary Medicine Amsterdam University Medical Center Amsterdam The Netherlands
Zobrazit více v PubMed
Abd‐Elaziz K, Jesenak M, Vasakova M, Diamant Z. Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseases. Curr Opin Pulm Med. 2021;27(1):54‐60. PubMed
Johnson JR, Wiley RE, Fattouh R, et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med. 2004;169(3):378‐385. PubMed
Ravanetti L, Dijkhuis A, Dekker T, et al. IL‐33 drives influenza‐induced asthma exacerbations by halting innate and adaptive antiviral immunity. J Allergy Clin Immunol. 2019;143(4):1355‐1370 e1316. PubMed
Ravanetti L, Dijkhuis A, Sabogal Pineros YS, et al. An early innate response underlies severe influenza‐induced exacerbations of asthma in a novel steroid‐insensitive and anti‐IL‐5‐responsive mouse model. Allergy. 2017;72(5):737‐753. PubMed
Marchant DJ, Bellac CL, Moraes TJ, et al. A new transcriptional role for matrix metalloproteinase‐12 in antiviral immunity. Nat Med. 2014;20(5):493‐502. PubMed
Abd‐Elaziz K, Voors‐Pette C, Wang KL, et al. First‐in‐man safety, tolerability, and pharmacokinetics of a novel and highly selective inhibitor of matrix Metalloproteinase‐12, FP‐025: results from two randomized studies in healthy subjects. Clin Drug Investig. 2021;41(1):65‐76. PubMed
